These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7781682

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S, Suzuki T, Misawa M, Nagase H.
    Eur J Pharmacol; 1999 Feb 26; 368(1):9-16. PubMed ID: 10096764
    [Abstract] [Full Text] [Related]

  • 43. Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun 26; 14(3):147-52. PubMed ID: 7941779
    [Abstract] [Full Text] [Related]

  • 44. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
    Ohsawa M, Nagase H, Kamei J.
    J Pharmacol Exp Ther; 1998 Aug 26; 286(2):780-7. PubMed ID: 9694934
    [Abstract] [Full Text] [Related]

  • 45. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H, Kampine JP.
    J Pharmacol Exp Ther; 2000 Feb 26; 292(2):576-83. PubMed ID: 10640294
    [Abstract] [Full Text] [Related]

  • 46. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 47. Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice.
    Kamei J, Kawashima N, Narita M, Suzuki T, Misawa M, Kasuya Y.
    Psychopharmacology (Berl); 1994 Jan 14; 113(3-4):318-21. PubMed ID: 7862839
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S, Zhang Z, Patterson N, Gulati A.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):62-71. PubMed ID: 20303944
    [Abstract] [Full Text] [Related]

  • 50. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.
    Nozaki C, Kamei J.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):160-2. PubMed ID: 17292346
    [Abstract] [Full Text] [Related]

  • 51. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP, Yeh GC, Yeh TK, Xi J, Loh HH, Law PY, Tao PL.
    Pharmacol Res; 2016 Sep 10; 111():867-876. PubMed ID: 27496654
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Different effects of NMDA/group I metabotropic glutamate receptor agents in delta- and mu-opioid receptor agonist-induced supraspinal antinociception.
    Suzuki T, Aoki T, Ohnishi O, Nagase H, Narita M.
    Eur J Pharmacol; 2000 May 12; 396(1):23-8. PubMed ID: 10822049
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.